Semaglutide causes greater reductions in HbA1c, body weight compared with Dulaglutide Medical Dialogues Bureau3 Feb 2018 8:30 PM ISTAccording to results of 40-week SUSTAIN 7 trial Published in The Lancet Diabetes & Endocrinology, patients of type 2 diabetes treated with...
Dulaglutide as effective as insulin glargine in diabetes with CKD : Lancet Medha Baranwal Baranwal22 Jun 2018 8:20 PM ISTIn patients with type 2 diabetes (T2D) and moderate-to-severe chronic kidney disease (CKD), treatment with dulaglutide produced glycaemic control...
Semaglutide manages diabetes and weight better than other GLP-1 receptor agonists Medha Baranwal Baranwal18 Aug 2018 8:10 PM ISTSwitching to semaglutide, a GLP-1 analog, from another GLP-1 receptor agonists (such as liraglutide, dulaglutide or exenatide) resulted in a further...
GLP-1 receptor agonist not associated with diabetic retinopathy Medha Baranwal Baranwal1 Jan 2019 7:20 PM ISTUSA: An analysis of the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS) database has revealed that glucagon-like peptide 1...
GLP-1 receptor agonist Dulaglutide cuts cardiovascular and kidney risk in diabetics, finds international study Hina Zahid10 Jun 2019 8:28 PM ISTOne of the longest ever study spanning over more than five years has found benefits of a cardiovascular risk-reducing agent in the field of diabetes....
